Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,185 | -5,145 | -3,781 | -1,438 | -1,865 |
| Depreciation Amortization | 1,439 | 603 | 80 | -189 | -142 |
| Accounts receivable | -335 | 0 | 1 | 4 | N/A |
| Other Working Capital | -484 | -306 | 972 | 94 | 438 |
| Other Operating Activity | 2,831 | 588 | 1,124 | 290 | 307 |
| Operating Cash Flow | $-7,733 | $-4,260 | $-1,604 | $-1,240 | $-1,262 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -215 | -61 | -110 | -7 | -11 |
| Net Acquisitions | 3,876 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -215 | 0 | -750 | N/A | N/A |
| Other Investing Activity | -464 | 15 | -800 | 0 | 0 |
| Investing Cash Flow | $3,197 | $-46 | $-910 | $-7 | $-11 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 2,310 | 2,425 | 695 | N/A |
| Debt Repayment | N/A | -264 | -16 | N/A | N/A |
| Common Stock Issued | 25,768 | 14,465 | 108 | N/A | 0 |
| Other Financing Activity | 0 | -28 | 0 | 0 | 0 |
| Financing Cash Flow | $25,768 | $16,483 | $2,517 | $695 | $0 |
| Exchange Rate Effect | -96 | 0 | N/A | N/A | N/A |
| Beginning Cash Position | 12,189 | 12 | 10 | 561 | 1,834 |
| End Cash Position | 33,325 | 12,189 | 12 | 10 | 561 |
| Net Cash Flow | $21,136 | $12,177 | $3 | $-552 | $-1,273 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,733 | -4,260 | -1,604 | -1,240 | -1,262 |
| Capital Expenditure | -221 | -61 | -110 | -7 | -11 |
| Free Cash Flow | -7,954 | -4,321 | -1,714 | -1,247 | -1,273 |